“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway

Janus tyrosine kinase (JAK) family of proteins have been identified as crucial proteins in signal transduction initiated by a wide range of membrane receptors. Among the proteins in this family JAK2 has been associated with important downstream proteins, including signal transducers and activators o...

Full description

Bibliographic Details
Main Authors: Emira Bousoik, Hamidreza Montazeri Aliabadi
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-07-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2018.00287/full
_version_ 1828847509197291520
author Emira Bousoik
Emira Bousoik
Hamidreza Montazeri Aliabadi
author_facet Emira Bousoik
Emira Bousoik
Hamidreza Montazeri Aliabadi
author_sort Emira Bousoik
collection DOAJ
description Janus tyrosine kinase (JAK) family of proteins have been identified as crucial proteins in signal transduction initiated by a wide range of membrane receptors. Among the proteins in this family JAK2 has been associated with important downstream proteins, including signal transducers and activators of transcription (STATs), which in turn regulate the expression of a variety of proteins involved in induction or prevention of apoptosis. Therefore, the JAK/STAT signaling axis plays a major role in the proliferation and survival of different cancer cells, and may even be involved in resistance mechanisms against molecularly targeted drugs. Despite extensive research focused on the protein structure and mechanisms of activation of JAKs, and signal transduction through these proteins, their importance in cancer initiation and progression seem to be underestimated. This manuscript is an attempt to highlight the role of JAK proteins in cancer biology, the most recent developments in targeting JAKs, and the central role they play in intracellular cross-talks with other signaling cascades.
first_indexed 2024-12-12T22:10:21Z
format Article
id doaj.art-2498ea0766784bac98d379930519d6da
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-12T22:10:21Z
publishDate 2018-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-2498ea0766784bac98d379930519d6da2022-12-22T00:10:15ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2018-07-01810.3389/fonc.2018.00287406787“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling PathwayEmira Bousoik0Emira Bousoik1Hamidreza Montazeri Aliabadi2Department of Biomedical and Pharmaceutical Sciences, Center for Targeted Drug Delivery, School of Pharmacy, Chapman University, Irvine, CA, United StatesSchool of Pharmacy, Omar Al-Mukhtar University, Dèrna, LibyaDepartment of Biomedical and Pharmaceutical Sciences, Center for Targeted Drug Delivery, School of Pharmacy, Chapman University, Irvine, CA, United StatesJanus tyrosine kinase (JAK) family of proteins have been identified as crucial proteins in signal transduction initiated by a wide range of membrane receptors. Among the proteins in this family JAK2 has been associated with important downstream proteins, including signal transducers and activators of transcription (STATs), which in turn regulate the expression of a variety of proteins involved in induction or prevention of apoptosis. Therefore, the JAK/STAT signaling axis plays a major role in the proliferation and survival of different cancer cells, and may even be involved in resistance mechanisms against molecularly targeted drugs. Despite extensive research focused on the protein structure and mechanisms of activation of JAKs, and signal transduction through these proteins, their importance in cancer initiation and progression seem to be underestimated. This manuscript is an attempt to highlight the role of JAK proteins in cancer biology, the most recent developments in targeting JAKs, and the central role they play in intracellular cross-talks with other signaling cascades.https://www.frontiersin.org/article/10.3389/fonc.2018.00287/fulljanus tyrosine kinases (JAKs)signal transducers and activators of transcription (STATs)cancersignaling pathwaysproliferationsurvival
spellingShingle Emira Bousoik
Emira Bousoik
Hamidreza Montazeri Aliabadi
“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
Frontiers in Oncology
janus tyrosine kinases (JAKs)
signal transducers and activators of transcription (STATs)
cancer
signaling pathways
proliferation
survival
title “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
title_full “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
title_fullStr “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
title_full_unstemmed “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
title_short “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
title_sort do we know jack about jak a closer look at jak stat signaling pathway
topic janus tyrosine kinases (JAKs)
signal transducers and activators of transcription (STATs)
cancer
signaling pathways
proliferation
survival
url https://www.frontiersin.org/article/10.3389/fonc.2018.00287/full
work_keys_str_mv AT emirabousoik doweknowjackaboutjakacloserlookatjakstatsignalingpathway
AT emirabousoik doweknowjackaboutjakacloserlookatjakstatsignalingpathway
AT hamidrezamontazerialiabadi doweknowjackaboutjakacloserlookatjakstatsignalingpathway